Straumann Holding AG (SAUHF)
USD 118.29
(0.73%)
USD 118.29
(0.73%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.55 Billion CHF | 2.44% |
| 2022 | 1.51 Billion CHF | 3.54% |
| 2021 | 1.46 Billion CHF | 9.63% |
| 2020 | 1.33 Billion CHF | 30.89% |
| 2019 | 1.02 Billion CHF | 54.9% |
| 2018 | 660.24 Million CHF | 8.51% |
| 2017 | 608.44 Million CHF | 33.36% |
| 2016 | 456.24 Million CHF | 3.38% |
| 2015 | 441.32 Million CHF | 4.1% |
| 2014 | 423.94 Million CHF | 9.16% |
| 2013 | 388.36 Million CHF | 174.65% |
| 2012 | 141.4 Million CHF | 0.89% |
| 2011 | 140.14 Million CHF | -11.45% |
| 2010 | 158.26 Million CHF | -5.53% |
| 2009 | 167.52 Million CHF | -12.1% |
| 2008 | 190.58 Million CHF | -40.99% |
| 2007 | 322.98 Million CHF | 125.28% |
| 2006 | 143.37 Million CHF | 23.29% |
| 2005 | 116.29 Million CHF | 25.17% |
| 2004 | 92.9 Million CHF | -3.04% |
| 2003 | 95.82 Million CHF | 56.94% |
| 2002 | 61.05 Million CHF | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.5 Billion CHF | -3.19% |
| 2023 Q2 | 1.52 Billion CHF | 0.62% |
| 2023 Q4 | 1.55 Billion CHF | 1.81% |
| 2023 FY | 1.55 Billion CHF | 2.44% |
| 2022 Q4 | 1.51 Billion CHF | 5.79% |
| 2022 Q2 | 1.43 Billion CHF | -2.12% |
| 2022 FY | 1.51 Billion CHF | 3.54% |
| 2021 Q2 | 1.44 Billion CHF | 8.17% |
| 2021 FY | 1.46 Billion CHF | 9.63% |
| 2021 Q4 | 1.46 Billion CHF | 1.35% |
| 2020 Q2 | 1.12 Billion CHF | 9.84% |
| 2020 Q4 | 1.33 Billion CHF | 19.17% |
| 2020 FY | 1.33 Billion CHF | 30.89% |
| 2019 Q2 | 977.58 Million CHF | 48.06% |
| 2019 Q4 | 1.02 Billion CHF | 4.62% |
| 2019 FY | 1.02 Billion CHF | 54.9% |
| 2018 Q2 | 623.46 Million CHF | 2.47% |
| 2018 Q4 | 660.24 Million CHF | 5.9% |
| 2018 FY | 660.24 Million CHF | 8.51% |
| 2017 Q2 | 532.07 Million CHF | 16.62% |
| 2017 Q4 | 608.44 Million CHF | 14.35% |
| 2017 FY | 608.44 Million CHF | 33.36% |
| 2016 Q4 | 456.24 Million CHF | -1.35% |
| 2016 Q2 | 462.47 Million CHF | 4.79% |
| 2016 FY | 456.24 Million CHF | 3.38% |
| 2015 FY | 441.32 Million CHF | 4.1% |
| 2015 Q4 | 441.32 Million CHF | -5.72% |
| 2015 Q2 | 468.1 Million CHF | 10.42% |
| 2014 Q4 | 423.94 Million CHF | 7.77% |
| 2014 FY | 423.94 Million CHF | 9.16% |
| 2014 Q2 | 393.39 Million CHF | 1.3% |
| 2013 Q4 | 388.36 Million CHF | 8.06% |
| 2013 Q2 | 359.38 Million CHF | 154.16% |
| 2013 FY | 388.36 Million CHF | 174.65% |
| 2012 Q2 | 166.19 Million CHF | 18.58% |
| 2012 FY | 141.4 Million CHF | 0.89% |
| 2012 Q4 | 141.4 Million CHF | -14.92% |
| 2011 Q2 | 127.76 Million CHF | -19.27% |
| 2011 FY | 140.14 Million CHF | -11.45% |
| 2011 Q4 | 140.14 Million CHF | 9.69% |
| 2010 FY | 158.26 Million CHF | -5.53% |
| 2010 Q4 | 158.26 Million CHF | -7.59% |
| 2010 Q2 | 171.26 Million CHF | 2.24% |
| 2009 Q4 | 167.52 Million CHF | 0.0% |
| 2009 FY | 167.52 Million CHF | -12.1% |
| 2008 FY | 190.58 Million CHF | -40.99% |
| 2007 FY | 322.98 Million CHF | 125.28% |
| 2006 FY | 143.37 Million CHF | 23.29% |
| 2005 FY | 116.29 Million CHF | 25.17% |
| 2004 FY | 92.9 Million CHF | -3.04% |
| 2003 FY | 95.82 Million CHF | 56.94% |
| 2002 FY | 61.05 Million CHF | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.34 Million USD | -66146.866% |
| Ansell Limited | 1.32 Billion USD | -17.053% |
| Ansell Limited | 1.33 Billion USD | -16.834% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 126.33 Million USD | -1132.172% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 943.17 Thousand USD | -164949.217% |
| Psykey, Inc. | 2.47 Million USD | -62821.829% |
| ConvaTec Group Plc | 2.01 Billion USD | 22.865% |
| ConvaTec Group Plc | 2.02 Billion USD | 22.974% |
| Encision Inc. | 1.98 Million USD | -78363.866% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 3.04 Million USD | -51099.104% |
| Innovative MedTech Inc. | 6.13 Million USD | -25274.7% |
| LifePoint, Inc. | 2.45 Million USD | -63330.758% |
| Medite Cancer Diagnostics, Inc. | 10.18 Million USD | -15190.227% |
| Paradigm Medical Industries, Inc. | 3.4 Million USD | -45685.235% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 3.04 Million USD | -51101.731% |
| Reflect Scientific, Inc. | 776.32 Thousand USD | -200420.398% |
| SmileDirectClub, Inc. | 982.26 Million USD | -58.481% |
| Sector 10, Inc. | 9.84 Million USD | -15711.38% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.35 Billion USD | -14.826% |
| SheerVision, Inc. | 1.43 Million USD | -108653.3% |
| United Health Products, Inc. | 1.99 Million USD | -77778.941% |
| Vasamed, Inc. | 1 Million USD | -154749.1% |
| Wearable Health Solutions, Inc. | 3.8 Million USD | -40862.665% |
| Yubo International Biotech Limited | 2.91 Million USD | -53322.739% |